Premium
Two private equity funds of Tata Capital Ltd have recorded their best-ever returns on an investment after selling their stake in pharmaceutical company Sai Life Sciences Ltd to US-based buyout firm TPG. TPG Capital Asia has acquired a significant minority stake in Sai Life Sciences from Tata Capital, the US firm ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
